Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 3
2010 15
2011 16
2012 11
2013 11
2014 9
2015 9
2016 5
2017 8
2018 30
2019 34
2020 28
2021 30
2022 17
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

197 results
Results by year
Filters applied: . Clear all
Page 1
ST-segment elevation myocardial infarction.
Vogel B, Claessen BE, Arnold SV, Chan D, Cohen DJ, Giannitsis E, Gibson CM, Goto S, Katus HA, Kerneis M, Kimura T, Kunadian V, Pinto DS, Shiomi H, Spertus JA, Steg PG, Mehran R. Vogel B, et al. Among authors: claessen be. Nat Rev Dis Primers. 2019 Jun 6;5(1):39. doi: 10.1038/s41572-019-0090-3. Nat Rev Dis Primers. 2019. PMID: 31171787 Review.
Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis.
Giacoppo D, Alfonso F, Xu B, Claessen BEPM, Adriaenssens T, Jensen C, Pérez-Vizcayno MJ, Kang DY, Degenhardt R, Pleva L, Baan J, Cuesta J, Park DW, Kukla P, Jiménez-Quevedo P, Unverdorben M, Gao R, Naber CK, Park SJ, Henriques JPS, Kastrati A, Byrne RA. Giacoppo D, et al. Among authors: claessen bepm. J Am Coll Cardiol. 2020 Jun 2;75(21):2664-2678. doi: 10.1016/j.jacc.2020.04.006. J Am Coll Cardiol. 2020. PMID: 32466881 Free article.
Identification and treatment of the vulnerable coronary plaque.
van Veelen A, van der Sangen NMR, Henriques JPS, Claessen BEPM. van Veelen A, et al. Among authors: claessen bepm. Rev Cardiovasc Med. 2022 Jan 20;23(1):39. doi: 10.31083/j.rcm2301039. Rev Cardiovasc Med. 2022. PMID: 35092231 Free article. Review.
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials.
Guedeney P, Giustino G, Sorrentino S, Claessen BE, Camaj A, Kalkman DN, Vogel B, Sartori S, De Rosa S, Baber U, Indolfi C, Montalescot G, Dangas GD, Rosenson RS, Pocock SJ, Mehran R. Guedeney P, et al. Among authors: claessen be. Eur Heart J. 2019 Jul 3:ehz430. doi: 10.1093/eurheartj/ehz430. Online ahead of print. Eur Heart J. 2019. PMID: 31270529
Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysis.
Guedeney P, Sorrentino S, Giustino G, Chapelle C, Laporte S, Claessen BE, Ollier E, Camaj A, Kalkman DN, Vogel B, De Rosa S, Indolfi C, Lattuca B, Zeitouni M, Kerneis M, Silvain J, Collet JP, Mehran R, Montalescot G. Guedeney P, et al. Among authors: claessen be. Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):225-235. doi: 10.1093/ehjcvp/pvaa024. Eur Heart J Cardiovasc Pharmacother. 2021. PMID: 32275743
Stent Technology Reaches Maturity?
Dangas GD, Claessen BE. Dangas GD, et al. Among authors: claessen be. JACC Cardiovasc Interv. 2020 Dec 28;13(24):2879-2881. doi: 10.1016/j.jcin.2020.10.004. JACC Cardiovasc Interv. 2020. PMID: 33357525 Free article. No abstract available.
Ticagrelor With or Without Aspirin in Chinese Patients Undergoing Percutaneous Coronary Intervention: A TWILIGHT China Substudy.
Han Y, Claessen BE, Chen SL, Chunguang Q, Zhou Y, Xu Y, Hailong L, Chen J, Qiang W, Zhang R, Luo S, Li Y, Zhu J, Zhao X, Cheng X, Wang J, Su X, Tao J, Sun Y, Wang G, Li Y, Bian L, Goel R, Sartori S, Zhang Z, Angiolillo DJ, Cohen DJ, Gibson CM, Kastrati A, Krucoff M, Mehta SR, Ohman EM, Steg PG, Liu Y, Dangas G, Sharma S, Baber U, Mehran R. Han Y, et al. Among authors: claessen be. Circ Cardiovasc Interv. 2022 Apr;15(4):e009495. doi: 10.1161/CIRCINTERVENTIONS.120.009495. Epub 2022 Mar 23. Circ Cardiovasc Interv. 2022. PMID: 35317615 Clinical Trial.
Long-term 5-year outcome of the randomized IMPRESS in severe shock trial: percutaneous mechanical circulatory support vs. intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction.
Karami M, Eriksen E, Ouweneel DM, Claessen BE, Vis MM, Baan J, Beijk M, Packer EJS, Sjauw KD, Engstrom A, Vlaar A, Lagrand WK, Henriques JPS. Karami M, et al. Among authors: claessen be. Eur Heart J Acute Cardiovasc Care. 2021 Dec 6;10(9):1009-1015. doi: 10.1093/ehjacc/zuab060. Eur Heart J Acute Cardiovasc Care. 2021. PMID: 34327527 Free PMC article. Clinical Trial.
197 results